- Joined
- Jul 13, 2007
- Messages
- 63,473
Completely different proposed mechanisms of action.
Paxlovid is a protease inhibitor, meaning it directly inhibits the key enzyme the virus RNA codes for off the bat that is used to chop up the rest of its RNA into individual bits for specific proteins. Without this enzyme, the virus can't hijack human ribosomes to make its own proteins and replicate. Protease inhibitors have been around for a while. If you look around on youtube you will find protease inhibitor videos from pre-Covid years modeling with molecular docking simulations how it works.
Ivermectin does not have a well understood mechanism. In vitro, ie in a petri dish in a lab, at very high concentrations it's been shown to affect the virus's binding of surface proteins and to also bind transport proteins in the cell. In human studies the concentrations of the medication are nowhere near this level, and it is thought to be more of an anti-inflammatory. No randomized placebo controlled trials have yet found legitimate evidence of benefit compared to placebo.
https://www.youtube.com/watch?v=XTTuUa6Di-c
Yep. Already posted about this new drug being a protease inhibitor:
Paxlovid is a 3CL Protease Inhibitor, a type of drug commonly used to treat AIDS.
It's unclear if this is a repurposed drug or new formulation. Various 3CL Protease Inhibitors have been under investigation for a while now:
Identification of SARS-CoV-2 3CL Protease Inhibitors
The following video is informative. Around the 11:20 mark, he talks about how Ivermectin also has 3CL Protease inhibition qualities.
It's basically Ivermectin.
Now if we want to discuss the bioavailability and concentration of the two drugs, that is also of interest. The new Pfizer drug is a combination drug, with another off-patent drug added. That off-patent addition, Ritonavir, is used to increase the availability of the other drug in the body.
So if the bio-concentration and availability are also an issue with Ivermectin (theoretically), why not combine Ivermectin with Ritonavir? Could it be that both drugs are off patent, and would not be as profitable? Pharma companies have held back life saving drugs in the past because they had to wait for more profitable, patented substitutes. This happened with a Hepatitis C cure, which was held back while people died.
Of course this new combination would not be necessary if Ivermectin in combination with Quercetin and Zinc is already effective. Those who actually treat patients believe that it is already effective. I am in no position to question them.
It would be nice if he addressed the big difference between Ivermectin and Paxlovid.
Paxlovid is a combination of two drugs. So it’s like Ivermectin plus another drug. The secondary drug is Ritonavir, which is used with a lot of combination therapies. Ritonavir slows down metabolism of the other drug, thus increasing it’s time, concentration and effectiveness in the body. It also has a lot of adverse effects.
The question would be does Ivermectin have a drug that helps it work better? The FLCCC certainly has a lot of supplements and drugs in their protocol that go along with Ivercmectin. It would be interesting to hear which ones play a role similar to what Ritonavir does, in other words, helping make Ivermectin more bioavailable.